380
Participants
Start Date
March 1, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
June 30, 2026
Goal-Directed Fluid Therapy (GDFT)
Norepinephrine will be administered intravenously at a rate of 0.06 µg/kg/min, followed by the implementation of fluid therapy guided by SVV until reaching our target. In instances where SVV ≤ 13%, indicative of adequate effective circulating blood volume, the fluid infusion rate will be adjusted to 1 ml/kg/h. Conversely, if SVV \> 13%, denoting inadequate effective circulating blood volume, a rapid infusion of 1 ml/kg of crystalloid fluid will be administered over 2 minutes, with subsequent observation of fluid reactivity after a further 2-minute interval. This process is reiterated until SVV ≤ 13% is attained. Should SVV \> 13% recurs during surgery, the aforementioned intervention is repeated.
Regular Fluid Therapy
Anesthesiologists will rely on their clinical expertise and intraoperative circulatory hemodynamic assessment to regulate fluid infusion rates and administer medications as necessary
NOT_YET_RECRUITING
General Hospital of Northern Theatre Command, Shenyang
RECRUITING
Renji Hospital, Shanghai
NOT_YET_RECRUITING
the First Affiliated Hospital of Zhengzhou University, Zhengzhou
RenJi Hospital
OTHER